Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 26, 2023 08:19 ET | Source: Biomerica, Inc.

Dubai Government Grants Insurance Reimbursement for Biomerica’s EZ Detect™ Colorectal Disease Screening Test

IRVINE, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that the Dubai government has officially approved insurance reimbursement for the EZ...
August 28, 2023 08:19 ET | Source: Biomerica, Inc.

Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors

Kenny has proven track record of driving growth at companies within the healthcare space and holds significant management and public company board experience, most recently as CEO of Meridian...
August 25, 2023 17:00 ET | Source: Biomerica, Inc.

Biomerica Reports Fiscal 2023 Year End Results

Revenues excluding Covid test sales increased 15% for fiscal 2023 vs fiscal 2022 Successfully completed inFoods® IBS pilot program with one of the largest Gastrointestinal physician groups in the US ...
August 03, 2023 08:19 ET | Source: Biomerica, Inc.

CVS Health to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Disease Screening Test

Over 7,000 CVS Pharmacy Stores to sell the EZ Detect™ TestSimple 2 minute at-home test detects an early warning sign of colorectal cancer IRVINE, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) --...
June 21, 2023 08:19 ET | Source: Biomerica, Inc.

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

Patent Claims Describe a Novel System to Predict and Help Prevent Adverse Food Reactions Using Personal Medical DataThe Patent further describes Algorithms to help Determine Safety Levels of Food...
May 18, 2023 08:19 ET | Source: Biomerica, Inc.

inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology

Gastro Health, a leading gastroenterology group, plans to utilize this simplified blood collection method when recommending the inFoods® IBS to their patients Biomerica also announced that inFoods®...
April 17, 2023 07:47 ET | Source: Biomerica, Inc.

Biomerica’s inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

Gastro Health is a leading gastroenterology group with over 380 GI physicians in the United StatesClinical study results show patients who eliminated foods as determined by the inFoods® IBS test...
April 14, 2023 16:48 ET | Source: Biomerica, Inc.

Biomerica Reports Q3 Fiscal 2023 Results

For the nine months ended February 28, 2023 vs. the same period in 2022, revenues, excluding sales of Covid-related products, increased by 16%.InFoods® IBS Laboratory Developed Test (LDT) validation...
March 08, 2023 08:19 ET | Source: Biomerica, Inc.

Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed

InFoods® IBS LDT validation testing at the CLIA Lab is completed and the product is now being offered commerciallyClinical trial data shows InFoods® IBS treatment diet significantly improved several...
March 07, 2023 16:39 ET | Source: Biomerica, Inc.

Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock

IRVINE, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, announced today the closing of its previously...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right